InsiderTrades

Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-14 · accession 0001839066-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2026-03-17 2026-03-14+ CLOV Reynoso Jamie L. CEO, Medicare Advantage F - Tax $1.98 -15.1K 2.72M -0.6% -$30.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-03-14 F D 8,945 $1.98 2,728,755 D — — (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022.
2 Common Class A Common Stock 2026-03-15 F D 6,187 $1.98 2,722,568 D — — (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.